Most people don't think about biotechs when the idea of investing in marijuana stocks comes up. However, several biotechs have cannabinoid drugs in their pipelines and therefore are often included in listings of pot stocks. One such biotech is GW Pharmaceuticals (NASDAQ: GWPH), which already has one cannabinoid product on the market in some countries and another one potentially on the way to approval in the U.S.